Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling

• DOI: 10.1073/pnas.95.22.13130
• Publication Date: 2002-07-26T14:40:11Z
• Authors: Masashi Narazaki; Minoru Fujimoto; Tomoshige Matsumoto; Yoshiaki Morita; Hiroshi Saito; Tadahiro Kajita; Kazuyuki Yoshizaki; Tetsuji Naka; Tadamitsu Kishimoto
• Keywords: Mice, Inbred BALB C; 0303 health sciences; Interleukin-6; Recombinant Fusion Proteins; Molecular Sequence Data; Intracellular Signaling Peptides and Proteins; Protein-Tyrosine Kinases; Peptide Fragments; Recombinant Proteins; Repressor Proteins; Mice; 03 medical and health sciences; COS Cells; Mutagenesis, Site-Directed; Animals; Humans; Point Mutation; Amino Acid Sequence; Carrier Proteins; Luciferases; Sequence Alignment; Conserved Sequence

Cytokine-inducible protein SSI-1 [signal transducers and activators of transcription (STAT)-induced STAT inhibitor 1, also referred to as SOCS-1 (suppressor of cytokine signaling 1) or JAB (Janus kinase-binding protein)] negatively regulates cytokine receptor signaling by inhibition of JAK kinases. The SSI family of proteins includes eight members that are structurally characterized by an SH2 domain and a C-terminal conserved region that we have called the SC-motif. In this study, we investigated the roles of these domains in the function of SSI-1. Results of reporter assays demonstrated that the pre-SH2 domain (24 aa in front of the SH2 domain) and the SH2 domain of SSI-1 were required for the suppression by SSI-1 of interleukin 6 signaling. Coexpression studies of COS7 cells revealed that these domains also were required for inhibition of three JAKs (JAK1, JAK2, and TYK2). Furthermore, deletion of the SH2 domain, but not the pre-SH2 domain, resulted in loss of association of SSI-1 with TYK2. Thus, SSI-1 associates with JAK family kinase via its SH2 domain, and the pre-SH2 domain is required for the function of SSI-1. Deletion of the SC-motif markedly reduced expression of SSI-1 protein in M1 cells, and this reduction was reversed by treatment with proteasome inhibitors, suggesting that this motif is required to protect the SSI-1 molecule from proteolytic degradation. Based on these findings, we concluded that three distinct domains of SSI-1 (the pre-SH2 domain, the SH2 domain, and the SC-motif) cooperate in the suppression of interleukin 6 signaling.